Enrichment Activity No. 2
Enrichment Activity No. 2
Enrichment Activity No. 2
COLLEGE OF PHARMACY
I. Objective
To identify the different finished product quality control tests conducted for parenteral.
II. Materials
Search engines like google, yahoo
Reference books like USP, BP, PP
III. Procedure
1. Research for at least 15 quality control tests conducted for finished product parenteral.
PHARMACEUTICAL ANALYSIS 2
UNIVERSITY OF PERPETUAL HELP SYSTEM DALTA
COLLEGE OF PHARMACY
Negative controls - water, free from endotoxins, added to the lysate solution
Turbidimetric technique
This test is based on the measurement of opacity change due to the formation of insoluble
coagulin
This technique is used for water systems and simple pharmaceutical products
Chromogenic technique
This is based on the measurement of color change which is caused by the release of the chromogenic
chemical
p-nitroanilide
The quantity of the p-nitroanilide produced is directly proportional to the endotoxin concentration
Uniformity of content
Procedures
30 sterile units are selected from each batch
The weight of 10 individual sterile unit is noted and the content is removed from them and
empty individual sterile unit is weighed accurately again
Then, the net weight is calculated by subtracting empty sterile unit weight from gross weight
The dose uniformity is met if the amount of active ingredient is within the range of 85-115.0% of
label claim
PHARMACEUTICAL ANALYSIS 2
UNIVERSITY OF PERPETUAL HELP SYSTEM DALTA
COLLEGE OF PHARMACY
If one unit is outside the range of 85-115.0%, and none of the sterile unit is outside the range of
75-125.0% or if the relative standard deviation of the resultant is greater than 6.0%, or if both
condition prevail, an additional 20 sterile unit should be tested.
The sterile units meet the requirements if not more than one unit is outside the range of 85-
115%, no unit is outside the range of 75-125.0% and the calculated relative standard deviation is
7.8%
Record the temperature of the animals beginning at least 90 min before injection and
continuing for 3 hours after injection
Any animal showing a temperature variation of 0.6 degree or more must not be used in main
test.
Pyrogen Test
The test involves measurement of the rise in body temperature of rabbits following the IV injection of a
sterile solution into ear vein of rabbit
Procedure:
Dose not exceeding 10ml per kg injected intravenously within a period of not more than 10min
Test animals: Use healthy, adult rabbits of either sex, preferably of the same variety.
Rabbit test
This test basically involves the injection sample solution which is to be tested into a Rabbits which are
use as test animals through ear vein. The Temperature sensing probe (Clinical Thermometer,
Thermosistor or similar probe) into a rectum cavity of Rabbit at the depth of 7.5 cm the test solution
must be warmed at 37 degrees prior to injection. Then Rectal temperature is recorded at 1,2,3 hr
subsequent to injection. This test is performed in separate area designed solely for this purpose under
environmental conditions similar to animal house should be free from disturbances that likely to excite
them. Initially this test is performed on 3 Rabbits but if required results are not obtained this test is
repeated on 5 additional Rabbits with same sample solution administer to initial 3 rabbits. Prior to 1hr of
injecting sample solutions the control temperatures of rabbits are determined. Use only those rabbits
whose control temperature is no vary by more than 1 degree Celsius.
PHARMACEUTICAL ANALYSIS 2
UNIVERSITY OF PERPETUAL HELP SYSTEM DALTA
COLLEGE OF PHARMACY
*Interpretation:- The solution is judged to be non pyrogenic if no single rabbit show rise in temperature
of 0.5 degree Celsius but if this condition is not met then the test if repeated on 5 additional rabbits with
same preparation administer to initial first 3 rabbits the solution is judged to be non pyrogenic if NMT 3
of 8 rabbits show individual temperature rise of 0.5 degree
Table No: 3: Limits for particle number as per IP, BP, EP, JP.
Small volume injections (< 100 3000 per container 300 per container
ml)
Sterility test
Growth promotion medium and incubation conditions are selected based on the test microorganism.
The sterility test is done using direct transfer and membrane filtration techniques. Membrane filtration
technique is suitable for liquids, soluble powders with bacteriostatic or fungi static properties, oils,
creams and ointments. Sterility test by direct transfer is performed by aseptic transfer of specified
volume from test container to culture medium and incubated for 14 days and visual observation of
medium is done on 3rd, 4th, 5th, 7th, 8th and 14th day. A membrane filter with porosity of 0.45μm with
diameter of 47mm with flow rate of 55-75 ml of water per minute at a pressure of 70 cm of mercury
should be used. The test meets the requirements when no growth is observed and if growth is observed
then the test is repeated in the second stage and generally second stage is repeated with double the
number of specimens tested in first stage when the test was found to be conducted under faulty or
inadequate aseptic techniques.
PHARMACEUTICAL ANALYSIS 2
UNIVERSITY OF PERPETUAL HELP SYSTEM DALTA
COLLEGE OF PHARMACY
*Interpretation: - If no visible evidence of microbial growth in culture medium in test tube then it is
interpreted that the sample representing lot is without intrinsic contamination. If visible microbial
growth is seen or if the test is judged to be invalid because of inadequate environmental conditions the
sterility test is repeated such interpretation must be made by those personnel who have adequate
knowledge of aseptic processing, industrial sterilization methods, and environmental control
procedures used in test facility.
Clarity of Solution
Clarity is performed to ensure that parenteral product is free from foreign particles Constitute the
injection as directed on the label.
b) The constituted injection is not significantly less clear than an equal volume of diluents for water for
injections contained in a similar container and examined in the same manner.
PHARMACEUTICAL ANALYSIS 2
UNIVERSITY OF PERPETUAL HELP SYSTEM DALTA
COLLEGE OF PHARMACY
Procedure
Empty the contents of one container & determine the volume of contents
The volume is not less than the amount stated on the label
Uniformity of weight
Procedure
Rinse with water & ethanol, dry at 100 degree Celsius to a constant weight
Visual method
In visual inspection, each injectable is inspected visually against white and black backgrounds.
The white background aids in detection of dark colored particles.
The light or reflective particles will appear against the black back ground. Some visual-enhancing
aids can increase the efficiency.
A magnifying lens at 2.5 × magnification set at the eye level facilitates the inspection.
Microscopic examination enhances detection of particulate matter in injectable. Visual
inspection gives the qualitative estimation of the particulate matter.
Acceptance Standards is that each container checked must not contain any visible particulate
matter.
Automated techniques
The automatic systems are also called as the electron particles counter. the electronic particles
counter evaluates the particles in injectables automatically.
PHARMACEUTICAL ANALYSIS 2
UNIVERSITY OF PERPETUAL HELP SYSTEM DALTA
COLLEGE OF PHARMACY
However, this method requires destruction of the ampoule/container for the particle
examination.
Electronic particles counting may be based on any one of the following principles: a) change in
electrical resistance, b) light blockages principle and c) light scattering. Some of the automated
systems for visual particle inspection include Autoskan, Eisai Ampoule inspection machine,
Schering PDS/A-V system, etc. Autoskan System.
The Autoskan system is based on light scattering principle whereby the particle in the path of a
light source causes the scattering of light. The scattered light is measured and provides the
corresponding information regarding the presence of particulate in the sample. This is a non-
destructive test.
Leakage test
Leakage test is employed to test the package integrity. Package integrity reflects its ability to keep the
product in and to keep potential contamination out.
It is because leakage occurs when a discontinuity exists in the wall of a package that can allow the
passage of gas under pressure or concentration differential existing across the wall. leak test methods.
VISUAL INSPECTION
Visual inspection is the easiest leak test method to perform. But this method is least sensitive..
The method is used for the evaluation of large volume parenteral. To increase the sensitivity of
the method, the visual inspection of the sample container may be coupled with the application
of vacuum to make leakage more readily observable.
This method is simple and inexpensive. However, the method is insensitive, operator
dependent, and qualitative.
Sometimes, the method is used in combination with pressure and /or temperature cycling to
accelerate leakage to improve sensitivity.
BUBBLE TEST
The test package is submerged in liquids. A differential pressure is applied on the container. The
container is observed for bubbles.
Sometimes, surfactant added liquid is used for immersion of test package. Any leakage is
evident after the application of differential pressure as the generation of foaming in immersion
liquid. The method is simple and inexpensive.
PHARMACEUTICAL ANALYSIS 2
UNIVERSITY OF PERPETUAL HELP SYSTEM DALTA
COLLEGE OF PHARMACY
The location of the leaks can be observed in this method. However, it is relatively insensitive and
the findings are operator dependent and are qualitative.
The optimized conditions can be achieved using a surfactant immersion fluid along with the dark
background and High intensity lighting. Generation of a differential positive pressure of 3 psi
inside the vial and observation of any leakage using magnifying glass within a maximum test
time of 15 minutes. Positive leak test result. Air bubbles
https://www.pharmatutor.org/articles/review-quality-control-of-parenteral-products
https://e-
currentscience.com/storage/app/archive/pdf/czcx1ekbW0o8rymgyPd6fLIYUeI8snpaCBX35jDa.pdf
https://www.slideshare.net/bharathpharmacist/ipqc-for-parenterals-39635925
PHARMACEUTICAL ANALYSIS 2